Related Experiment Video
Updated: Aug 8, 2026

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
Long-term care after percutaneous coronary intervention: focus on the role of antiplatelet therapy
Gregg W Stone1, Herbert D Aronow
1Columbia University Medical Center and Cardiovascular Research Foundation, New York, NY 10022, USA. gstone@crf.org
Insights
Dual antiplatelet therapy, including aspirin and clopidogrel, is crucial for preventing complications after percutaneous coronary intervention (PCI). This regimen effectively reduces stent thrombosis and future atherothrombotic events when used long-term.
Area of Science:
- Cardiology
- Vascular Medicine
- Pharmacology
Background:
- Percutaneous coronary intervention (PCI) can cause arterial wall injury, leading to platelet activation and thrombosis.
- Platelet hyperreactivity is a known factor in atherothrombosis and a complication of PCI, including acute/subacute thrombosis and restenosis.
Purpose of the Study:
- To evaluate the efficacy of antithrombotic and anticoagulant therapies in minimizing thrombotic complications post-PCI.
- To determine optimal dual antiplatelet therapy (DAPT) duration for preventing stent thrombosis.
- To outline comprehensive long-term care strategies for patients undergoing PCI.
Main Methods:
- Comparison of aspirin plus thienopyridine therapy versus aspirin plus heparin and warfarin.
- Assessment of DAPT (aspirin and clopidogrel) duration for bare-metal and drug-eluting stents.
- Review of systemic pharmacotherapy and lifestyle modifications for managing coronary atherothrombosis.
Main Results:
- Aspirin plus a thienopyridine is more effective than aspirin/heparin/warfarin in preventing ischemic events and bleeding.
- DAPT with aspirin and clopidogrel is recommended for at least 4 weeks (bare-metal stents) to 3-6 months (drug-eluting stents).
- Long-term DAPT (aspirin plus clopidogrel) for at least 12 months is advised for prophylaxis against future atherothrombotic events.
Conclusions:
- Dual antiplatelet therapy with aspirin and clopidogrel is the preferred regimen for minimizing thrombotic complications after PCI.
- Comprehensive management including pharmacotherapy and lifestyle changes is essential for long-term atherothrombosis risk reduction.
- Extended DAPT duration is critical for preventing both early and late stent thrombosis and subsequent atherothrombotic events.
Abstract:
Arterial wall injury caused by percutaneous coronary intervention (PCI) triggers transient platelet activation and mural thrombosis; these effects are superimposed on the preexisting platelet hyperreactivity associated with underlying atherothrombosis. Platelet activation has been implicated in the major complications of PCI: acute and subacute thrombosis and restenosis. Antithrombotic and anticoagulant therapy minimizes thrombotic complications after PCI. Aspirin plus a thienopyridine (ticlopidine or clopidogrel) is more effective than aspirin plus heparin and extended warfarin therapy in preventing periprocedural ischemic events and subsequent stent thrombosis and results in less major and minor bleeding. Dual antiplatelet therapy with aspirin and clopidogrel (the preferred thienopyridine because of its superior hematologic safety) is recommended for at least 4 weeks to prevent subacute stent thrombosis with bare-metal stents and 3 to 6 months to prevent late-stent thrombosis with drug-eluting stents. Coronary atherothrombosis is a diffuse vascular disease, and reduction of the risk of future ischemic events requires strategies that extend beyond the focal treatment of stenotic lesions. Optimal long-term care after PCI requires aggressive systemic pharmacotherapy (antiplatelet agents, statins, beta-blockers, and angiotensin-converting enzyme Inhibitors) in conjunction with therapeutic lifestyle changes (smoking cessation, weight reduction, dietary measures, and exercise). In this context, dual antiplatelet therapy (aspirin plus clopidogrel) is recommended for at least 12 months after PCI for prophylaxis of future atherothrombotic events.
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Angina IV: Management
Atherosclerosis III: Management
Peripheral Artery Disease V: Postoperative Nursing Management